mbiomics is a biotechnology company.
mbiomics has raised $12.0M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
mbiomics's investors include HTGF (High-Tech Gruenderfonds), Bayern Kapital, MIG Fonds, MIG Capital.
mbiomics is headquartered in Munich, Germany.
mbiomics is a biotechnology company.
mbiomics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"mbiomics — Funding & Investors." VCBacked, April 28, 2026, https://www.vcbacked.co/company/mbiomics. Accessed July 20, 2026.
VCBacked. (2026). mbiomics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/mbiomics
{{cite web |title=mbiomics — Funding & Investors |url=https://www.vcbacked.co/company/mbiomics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated